LGALS3 and coronary artery disorder: Despite the relation between Gal-3 and cardiovascular events in CAD patients [43], [44], combination data between Gal-3 (LGALS-3 rs4652) gene variant and its gene expression levels with the risk of CAD in T2DM patients among an Egyptian population have not been published to date.